Clinical Trials on Acute Lymphoblastic Leukemia Not Having Achieved Remission in India
Total 8 results
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States, Egypt, India
-
PfizerCompletedAdult Relapsed/Refractory B Cell Acute Lymphoblastic LeukemiaIndia
-
PfizerCompletedLeukemia | Precursor b-Cell Lymphoblastic Leukemia-Lymphoma | ACUTE LYMPHOBLASTIC LEUKEMIAUnited States, Spain, Taiwan, Singapore, India, Hungary, Turkey, Poland
-
Columbia UniversityTata Memorial HospitalUnknown
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Withdrawn
-
University of Geneva, SwitzerlandAll India Institute of Medical Sciences, New Delhi; Swiss National Science... and other collaboratorsRecruitingPharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia (MPGx-INDALL)Drug Effect | Pediatric Cancer | Adverse Drug Event | Drug Interaction | ALL, Childhood | Drug Toxicity | Toxicity, Drug | Relapse LeukemiaIndia
-
Columbia UniversityInternational Agency for Research on CancerRecruitingAcute Lymphoblastic Leukemia | Nutrition Aspect of Cancer | Genetic Predisposition | MicrotiaUnited States, Guatemala, Brazil, Honduras, India, Tanzania
-
Aurigene Discovery Technologies LimitedRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Non Hodgkin Lymphoma | Solid Tumor, AdultIndia